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Abstract
Background: Ultrasound-guided vacuum-assisted breast biopsy technology is extremely useful for
diagnostic biopsy of suspicious breast lesions and for attempted complete excision of appropriately
selected presumed benign breast lesions.
Case presentation: A female patient presented with 16 breast lesions (eight within each breast),
documented on ultrasound and all presumed to be fibroadenomas. Over a ten and one-half month
period of time, 14 of these 16 breast lesions were removed under ultrasound guidance during a
total of 11 separate 8-gauge Mammotome® excision procedures performed during seven separate
sessions. Additionally, two of these 16 breast lesions were removed by open surgical excision. A
histopathologic diagnosis of fibroadenoma and/or fibroadenomatous changes was confirmed at all
lesion excision sites. Interval follow-up ultrasound imaging revealed no evidence of a residual lesion
at the site of any of the 16 original breast lesions.
Conclusion: This report describes an innovative approach of utilizing ultrasound-guided 8-gauge
vacuum-assisted breast biopsy technology for assisting in achieving complete eradication of multiple
bilateral fibroadenomas in a patient who presented with 16 documented breast lesions. As such,
this innovative approach is highly recommended in similar appropriately selected patients.
Background
The Mammotome® breast biopsy system (Ethicon Endo-
Surgery, Inc., Cincinnati, Ohio) is an innovative vacuum-
assisted breast biopsy technology which currently has ster-
eotactic, ultrasound, and magnetic resonance imaging
(MRI) applications and is available in 8-gauge, 11-gauge,
and 14-gauge platforms [1].
Ultrasound-guided applications of the 8-gauge platform
of this particular system are well described in the literature
[2-10]. In a recently published series of 304 cases, this spe-
cific ultrasound-guided 8-gauge vacuum-assisted breast
biopsy system was comprehensively evaluated both for
the diagnostic biopsy of suspicious breast lesions and for
attempted complete excision of appropriately selected
presumed benign breast lesions [10]. In this recently
reported series, 100% of all suspicious ultrasound lesions
were accurately diagnosed (with the demonstration of no
false-negative results) and 89% of ultrasound lesions that
were presumed to be completely excised by the 8-gauge
technique were verified as absent on interval follow-up
ultrasound at a median time of 6 months [10].
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The present report describes an innovative approach of
utilizing an ultrasound-guided vacuum-assisted excision
technique with the 8-gauge breast biopsy system
described above [2-10] for assisting in achieving complete
eradication of multiple bilateral fibroadenomas in a
patient who presented with 16 documented breast
lesions.
Case presentation of technical innovation
A 21 year-old, healthy, white female presented to our
comprehensive breast health services facility with multi-
ple bilateral breast lesions that were presumed to repre-
sent multiple bilateral fibroadenomas. She reported
having previously undergone a surgical excision proce-
dure of a fibroadenoma of each of her breasts at a local
community hospital at a time of approximately three
years prior to her current presentation.
Prior to her current presentation at our facility, the patient
was evaluated at an out-of-state university medical center
and was noted to have multiple ultrasound lesions within
both of her breasts. Due to the multiplicity of the bilateral
breast lesions and the complexity of her particular case,
the breast surgeon at that out-of-state university medical
facility told the patient and her family that her "only real-
istic option" was for bilateral nipple-sparing mastecto-
mies and expander-to-implant reconstruction.
Upon her presentation to our facility, the patient reported
that she had noticed an enlarging mass of her central right
breast over the last two years and two smaller palpable
masses of her left breast. On clinical breast examination,
she had medium-sized breasts (36-C cup size). She had an
old surgical scar extending from the 8 to 10 o'clock axis of
the periareolar aspect of her right breast and similar surgi-
cal scar extending from the 10 to 12 o'clock axis of the
periareolar aspect of her left breast. Most remarkably, she
was noted to have a 10 cm × 7 cm × 5 cm clinically palpa-
ble mass encompassing her entire right breast and an
overlying 1.5 cm clinically palpable mass in the in the 3
o'clock axis of the periareolar aspect of her right breast.
Two palpable masses were also noted in her left breast,
clinically measuring 3 cm in size in the 3 to 4 o'clock axis
of the mid-breast field and 2 cm in size in the subareolar
region. No axillary, supraclavicular, or cervical adenopa-
thy was noted. The patient also reported being on hormo-
nal contraception for the past five years. For the last 18
months, she was maintained on a combination transder-
mal contraception product containing norelgestromin (6
mg) and ethinyl estradiol (0.75 mg).
Bilateral breast imaging was performed with both bilateral
whole-breast ultrasound and bilateral breast MRI. Ulti-
mately, a total of 16 separate breast lesions were identified
on both ultrasound and MRI, consisting of eight lesions
documented in each breast (Table 1).
As a result of the radical and body-altering surgical inter-
vention recommendations for bilateral nipple-sparing
mastectomies and expander-to-implant reconstruction
that were made by the breast surgeon at an out-of-state
university medical center, as well as due to her enlarging
bilateral breast masses, both the patient and her parents
were highly anxious and concerned. Both the patient and
her parents desperately desired an alternative therapeutic
approach to deal with her multiple bilateral breast lesions
and that could accomplish the same goal of complete
removal of all detectable lesions while drastically mini-
mizing the degree of surgical invasiveness and maximiz-
ing the cosmetic outcome.
A total of 11 separate 8-gauge vacuum-assisted excision
procedures, using the previously described breast biopsy
system [2-10], were performed to a total of 14 different
ultrasound lesions during seven separate sessions over a
ten and one-half month period of time (Table 2). The
technique used for all 11 of the ultrasound-guided 8-
gauge vacuum-assisted excision procedures performed in
this current report has been previously described and
reported by the present author [10]. Real-time ultrasound
guidance was performed using the Philips HDI 5000
SonoCT system (Philips Medical Systems Andover, Massa-
chusetts), with a variable frequency transducer L12-5
(range 4.75 to 10.0 MHz). After local anesthetic was
administered to the proposed 8-gauge vacuum-assisted
excision site, a 5 mm skin incision was made with a #11
blade. Then, under real-time ultrasound guidance, the 8-
gauge vacuum-assisted device was passed through the 5
mm skin incision and positioned just beneath the ultra-
sound lesion (Figure 1) and multiple 8-gauge cores were
consecutively harvested while sequentially rotating the 8-
gauge vacuum-assisted device over an array spanning
approximately 180 degrees. Ongoing ultrasound assess-
ment of the progression of lesion excision and final verifi-
cation of presumed complete lesion excision was
performed in real-time in both the longitudinal and trans-
verse planes to the long axis of the 8-gauge device. After
completion of core acquisition, the 8-gauge device was
removed and a 14-gauge Cormark™ rigid microclip device
(Ethicon Endo-Surgery, Inc., Cincinnati, Ohio) was
inserted through the same breast parenchymal track under
real-time ultrasound guidance for placement of a micro-
clip into the excision cavity (Figure 2). A single microclip
was placed at the site of each ultrasound-guided 8-gauge
vacuum-assisted excision procedures, except for that of
the ultrasound-guided 8-gauge vacuum-assisted excision
procedure for lesions 11 and 12, in which case two adja-
cent microclips were placed. Thereafter, as a standard and
to assure adequate hemostasis, manual compression toWorld Journal of Surgical Oncology 2007, 5:124 http://www.wjso.com/content/5/1/124
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the breast was performed for approximately ten minutes.
No peri-procedural bleeding complications occurred.
Finally, the 5 mm incision site was reapproximated with
standard adhesive skin closure strips.
A histopathologic diagnosis of fibroadenoma and/or
fibroadenomatous changes was confirmed from all 11 of
the ultrasound-guided 8-gauge vacuum-assisted excision
procedures performed.
The patient's hormonal contraception was discontinued
after her third ultrasound-guided 8-gauge vacuum-
assisted excision session. A resultant decrease in lesion
size was noted in lesion number 9, 13, and 14 on repeat
Table 2: Summary of all eleven separate ultrasound-guided 8-gauge vacuum-assisted excision procedures.
Procedure 
number
Session 
number
Lesion excised 
from Table 1
Duration of time from presentation
 to procedure in months
Number of 8-gauge
 cores harvested
Overall estimated 3-dimensions of 8-gauge 
cores harvested in centimetres (cm)
1 1 10 1.0 10 3.6 × 2.1 × 0.4
2 1 11,12 1.0 12 4.1 × 2.9 × 0.4
3 2 15 1.5 6 2.0 × 2.0 × 0.4
4 2 16 1.5 5 2.0 × 1.7 × 0.3
5 3 6 3.5 5 2.5 × 2.0 × 0.3
6 3 8 3.5 13 3.0 × 2.5 × 0.5
7 4 3,4,5 4.5 16 3.2 × 2.6 × 0.4
8 4 7 4.5 15 2.5 × 2.5 × 0.5
9 5 13 7.5 20 3.0 × 3.0 × 1.0
10 6 14 9.0 28 3.5 × 3.0 × 1.0
11 7 9 10.5 32 5.1 × 3.2 × 1.1
Table 1: Characteristics of all sixteen breast lesions visualized on ultrasound examination.
Lesion# Breast Ultrasound location† * Palpable Ultrasound lesion size (cm) Ultrasound lesion volume (cm3)‡
1 Right Central/Subareolar Yes 9.63 × 8.28 × 4.94 206.24
2 Right 3 o'clock (zone 1) Yes 1.53 × 1.51 × 1.17 1.41
3 Right 9 o'clock (zone 3) No 1.25 × 0.76 × 0.40 0.2
4 Right 9 o'clock (zone 3) No 0.73 × 0.72 × 0.64 0.18
5 Right 9 o'clock (zone 3) No 0.62 × 0.46 × 0.32 0.05
6 Right 10 o'clock (zone 2) No 0.66 × 0.64 × 0.41 0.09
7 Right 10 o'clock (zone 3) No 1.43 × 1.34 × 0.80 0.8
8 Right 11 o'clock (zone 2) No 1.24 × 0.81 × 0.46 0.24
9 Left Central/Subareolar Yes 2.87 × 2.46 × 1.27¶ 4.69¶
10 Left 12 o'clock (zone 2) No 0.96 × 0.77 × 0.36 0.14
11 Left 2 o'clock (zone 2) No 0.96 × 0.84 × 0.53 0.22
12 Left 2 o'clock (zone 2) No 0.91 × 0.84 × 0.39 0.16
13 Left 3 to 4 o'clock (zone 1) Yes 1.39 × 1.32 × 0.77§ 0.74§
14 Left 3 to 4 o'clock (zone 2) Yes 3.30 × 2.85 × 1.48* 7.29*
15 Left 4 o'clock (zone 2) No 0.87 × 0.79 × 0.36 0.13
16 Left 7 to 8 o'clock (zone 1) No 0.55 × 0.53 × 0.25 0.04
† The location of each breast lesion seen on ultrasound was reported using its "o'clock" location and its 1, 2, or 3 "zone" location relative to the 
distance from the nipple (i.e., zone 1 is the central-third of the breast field, zone 2 is the middle-third of the breast field, and zone 3 is peripheral-
third of the breast field) [20, 21].
* All sixteen breast lesions visualized on ultrasound were also identified on MRI. However, the three closely approximated lesions (lesion #3, #4, 
and #5) that were ultimately identified on ultrasound in the 9 o'clock axis of zone 3 of the right breast could not be distinguished as three separate 
areas of enhancement on MRI, but appeared as one vaguely defined area of enhancement on MRI.
‡ The volume of the ultrasound lesion was calculated using the formula of the volume of an ellipsoid [4/3·π·length axis radius·width axis radius·height 
axis radius], rather than using the formula of the volume of a cuboid [length·width·height], since the three-dimensional shape of any given 
ultrasound lesion generally better approximated that of an ellipsoid rather than that of a cuboid [10].
¶ Seven months after stopping hormonal contraception, lesion #9 measured 2.35 × 1.63 × 0.79 cm in size (volume 1.58 cm3), consisting of a 166% 
volume reduction.
§ Four months after stopping hormonal contraception, lesion #13 measured 1.34 × 1.27 × 0.69 cm in size (volume 0.61 cm3), consisting of a 37% 
volume reduction.
£Five and one-half months after stopping hormonal contraception, lesion #14 measured 2.12 × 1.91 × 0.98 cm in size (volume 2.08 cm3), consisting 
of a 186% volume reduction.World Journal of Surgical Oncology 2007, 5:124 http://www.wjso.com/content/5/1/124
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diagnostic ultrasound (Table 1) performed at a later time
but prior to the time of the last three ultrasound-guided 8-
gauge vacuum-assisted excision sessions (session number
5, 6, and 7) for lesion number 13, 14, and 9, respectively
(Table 2). This effect appeared to be directly related to the
discontinuation of her hormonal contraception (Table 1).
This ultimately allowed for successful complete ultra-
sound-guided 8-gauge vacuum-assisted excision of the
two lesions (lesion number 9 and 14) that were previ-
ously deemed as too large for consideration of attempted
ultrasound-guided 8-gauge vacuum-assisted excision.
Between the fourth and fifth ultrasound-guided 8-gauge
vacuum-assisted excision sessions, the patient was taken
to the operating room and underwent surgical excision of
two right breast lesions. This consisted of a giant fibroad-
enoma (Figure 3) encompassing her entire central right
breast (lesion number 1, Table 1) that measured 10.5 ×
8.0 × 5.5 cm in size on gross pathologic evaluation, as well
as an additional fibroadenoma in the 3 o'clock axis of the
periareolar aspect of her right breast (lesion number 2,
Table 1) that measured 1.5 × 1.2 × 0.9 cm in size on gross
pathologic evaluation and which was located in close
proximity along the superficial lateral aspect of the giant
fibroadenoma. As is shown in Figure 3, for the surgical
excision of these two right breast lesions, the patient's
right breast was approached through a 10 cm inframam-
mary incision. Through this inframammary incision, the
entire right breast parenchymal tissue plate was elevated
off of the underlying right pectoralis major muscle and the
giant fibroadenoma was delivered out through the poste-
rior breast tissue plate by incising the very thin rim of pos-
teriorly compressed breast parenchyma lying just beneath
the giant fibroadenoma. In this manner, the giant fibroad-
enoma and the second closely-adjacent smaller fibroade-
noma were removed without placing any incisions upon
the face of the right breast and without incising though
any breast parenchyma other than the thin rim of posteri-
orly compressed breast parenchyma lying beneath the
giant fibroadenoma. This particular surgical approach was
instrumental to maximizing the cosmetic outcome.
Approximately 18 months after the first ultrasound-
guided 8-gauge vacuum-assisted excision procedure and
approximately 8 month after the last ultrasound-guided
8-gauge vacuum-assisted excision procedure, the patient
returned for interval follow-up and underwent bilateral
digital mammography and bilateral whole breast ultra-
sound. Bilateral digital mammography (Figure 4) showed
Intraoperative photograph showing removal of the giant  fibroadenoma through an inframammary incision after the  entire right breast parenchymal tissue plate was elevated off  of the underlying right pectoralis major muscle Figure 3
Intraoperative photograph showing removal of the giant 
fibroadenoma through an inframammary incision after the 
entire right breast parenchymal tissue plate was elevated off 
of the underlying right pectoralis major muscle.
Ultrasound image in longitudinal axis showing the 8-gauge  vacuum-assisted device positioned just beneath the ultra- sound lesion once the cutter blade has been fully activated  across the aperture of the tissue collection chamber Figure 1
Ultrasound image in longitudinal axis showing the 8-gauge 
vacuum-assisted device positioned just beneath the ultra-
sound lesion once the cutter blade has been fully activated 
across the aperture of the tissue collection chamber.
Ultrasound image in longitudinal axis showing a 14-gauge  Cormark™ microclip marking the area of the 8-gauge vac- uum-assisted excision of the previous ultrasound lesion Figure 2
Ultrasound image in longitudinal axis showing a 14-gauge 
Cormark™ microclip marking the area of the 8-gauge vac-
uum-assisted excision of the previous ultrasound lesion.World Journal of Surgical Oncology 2007, 5:124 http://www.wjso.com/content/5/1/124
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multiple clips within both breasts marking the areas of the
11 separate ultrasound-guided 8-gauge vacuum-assisted
excision procedures that were performed during seven
separate ultrasound-guided 8-gauge vacuum-assisted exci-
sion sessions. Bilateral whole breast ultrasound showed
no residual ultrasound lesions at any of the sites of the 11
separate ultrasound-guided 8-gauge vacuum-assisted exci-
sion procedures and no residual ultrasound lesions at the
sites of the two surgically excised right breast fibroadeno-
mas. Likewise, bilateral whole breast ultrasound showed
no new apparent ultrasound lesions elsewhere in either
breast.
Discussion
Numerous reports in the literature describe to varying
degrees the use of the previously mentioned ultrasound-
guided breast biopsy system for attempted removal of
appropriately selected presumed benign breast lesions by
both the 11-gauge platform [2-9,11-17] and the 8-gauge
platform [2-10]. However, to date, there has not been a
single report in the literature that addresses how this par-
ticular 8-gauge system can be used for optimally manag-
ing a patient who may present with multiple bilateral
presumed benign breast lesions.
The current report represents the first account in the liter-
ature to describe the use of an ultrasound-guided 8-gauge
vacuum-assisted breast biopsy system as the predominant
interventional method of excision for attempting com-
plete eradication of multiple bilateral fibroadenomas in
an individual patient who presented with 16 documented
breast lesions. In this particular patient, this innovative
ultrasound-guided approach allowed for accomplishing
complete excision of 14 separate breast lesions with virtu-
ally no aesthetic alterations to her breasts. As a result,
maximal and optimal cosmetic outcome was attained and
much more radical and body-altering surgical interven-
tion (such as the bilateral nipple-sparing mastectomies
and expander-to-implant reconstruction that was previ-
ously recommended by the breast surgeon at an out-of-
state university medical center) was completely avoided in
this particular case. Therefore, the presentation of this case
nicely illustrates the contention of the present author that
this ultrasound-guided 8-gauge vacuum-assisted excision
technique should be considered as a viable alternative or
as an adjunct to consideration of much more radical open
surgical approaches when faced with the daunting task of
removing multiple bilateral fibroadenomas. As such, this
innovative approach is highly recommended in similar
appropriately selected patients.
The discontinuation of the patient's hormonal contracep-
tion appeared to be highly effective in successfully reduc-
ing the size of two of the left breast lesions (lesion number
9 and 14) and was therefore crucial in allowing for suc-
cessful complete excision of these two lesions that were
previously deemed as too large for consideration of
attempted excision by the ultrasound-guided 8-gauge vac-
uum-assisted excision technique, based on the current
author's previously published size and shape criteria for
predicting successful lesion excision [10]. The concept of
hormonal contraception stimulating the growth of pre-
existing fibroadenomas is not a new one [18,19] and this
concept is further re-enforced by the findings presented
within the current report. Therefore, consideration of a
trial period of discontinuation of hormonal contraception
can be used to attempt to convert a difficult situation in
which surgical excision of one or more fibroadenomas is
being contemplated to that of a more ideal situation in
which attempted ultrasound-guided 8-gauge vacuum-
assisted excision is possible.
Frequently, when a patient presents with a palpable event
that represents a fibroadenoma, it is not uncommon to
identified one or more additional lesions within the ipsi-
lateral breast or contralateral breast on diagnostic breast
ultrasound that represent other nonpalpable fibroadeno-
Bilateral digital mammography Figure 4
Bilateral digital mammography. Upper left panel is right cra-
nial-caudal view. Upper right panel is left cranial-caudal view. 
Lower left panel is right medial-lateral-oblique view. Lower 
right panel is left medial-lateral-oblique view. Four individual 
microclips are visible within the right breast and eight individ-
ual microclips are visible within the left breast.World Journal of Surgical Oncology 2007, 5:124 http://www.wjso.com/content/5/1/124
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mas candidates. This particular situation represents a sce-
nario that is extremely appropriate for consideration of
using an 8-gauge vacuum-assisted breast biopsy system
for attempting ultrasound-guided excision of all pre-
sumed fibroadenoma candidates. Such an innovative and
pro-active approach may allow for achieving complete
eradication of multiple fibroadenomas candidates and
avoiding later surgical excision of these lesions if their
continued growth pattern were to later preclude future
attempted ultrasound-guided 8-gauge vacuum-assisted
excision. This approach would be particularly useful for
those patients who you may suspect are inclined not to
adhere to a regimented follow-up schedule for ongoing
monitoring of such lesions that you may otherwise leave
in place for such an ongoing monitoring strategy. Like-
wise, this approach would also be particularly useful for
those patients on hormonal contraception in whom you
are concerned about ongoing stimulation of the growth
pattern of pre-existing fibroadenomas in order to prevent
a situation in which a fibroadenoma which was previ-
ously amendable to attempted ultrasound-guided 8-gauge
vacuum-assisted excision then becomes only removable
by a surgical excision procedure. For obvious reasons,
such an approach which maximizes cosmetic outcome by
eliminating the necessity for creating major surgical scars
on the breast is one that is of particular importance to
young female patients and should be factored into the
decision-making process of how to manage these patients.
As a last point of interest, and has been previously dis-
cussed by the present author [10], the ultrasound-guided
8-gauge vacuum-assisted excision technique allows for
on-going, real-time, ultrasound-guided "tailoring" of the
excision cavity of any given presumed benign lesion that
the operator is attempting to completely excise at the time
of the procedure. This technique allows the operator to
remove only as much tissue as is needed to attempt com-
plete excision of any given presumed benign lesion. This
can be particularly important in smaller-breasted women
in whom lesion excision volume may be crucial in deter-
mining cosmetic outcome, especially when multiple
fibroadenoma candidates are encountered. This clearly
represents a significant potential advantage over that of
using a percutaneous en bloc excision technique for
attempted complete lesion excision, since such percutane-
ous en bloc techniques generally afford only a single
attempt at tissue acquisition and may have a greater theo-
retical risk for requiring an additional diagnostic proce-
dure for complete lesion excision when inaccurate device
positioning results in incomplete lesion removal in the
intended region of initial en bloc tissue acquisition.
Conclusion
This report describes, for the first time, an innovative
approach of utilizing an ultrasound-guided vacuum-
assisted excision technique with the previously men-
tioned 8-gauge breast biopsy system [2-10] for assisting in
achieving complete eradication of multiple bilateral
fibroadenomas in a patient who presented with 16 docu-
mented breast lesions. Successful complete excision of 14
separate lesions was accomplished with the previously
mentioned 8-gauge breast biopsy system [2-10]. Discon-
tinuation of the patient's hormonal contraception was
crucial in allowing for successful complete excision of two
lesions that were previously deemed as too large for con-
sideration of attempted ultrasound-guided 8-gauge vac-
uum-assisted excision. As such, this innovative approach
is highly recommended in similar appropriately selected
patients.
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